NASDAQ:CDNA

Caredx Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy CDNA

*Your capital is at risk

$38.37

-1.36 (-3.42%)

At Close: Jul 20, 2026

CareDx Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -75.59. In total, the insiders bought 1.2M and sold 514.58K CDNA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-75.59
● Buy	1.2M shares
● Sell	514.58K shares
55% Buy Activity Moderate Negative Correlation
Sell Signal High Confidence Jul 16, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -75.59. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 01, 2026 Sell	Common Stock F-InKind	Kennedy Keith CFO & COO	C-Suite Officer	11 725 Value: $209.5K
Apr 01, 2026 Sell	Common Stock F-InKind	Hanna John Walter Jr President And CEO	CEO / President	35 037 Value: $626.1K
Apr 01, 2026 Sell	Common Stock F-InKind	Meng Jessica Chief Commercial Officer	Officer	7 386 Value: $132.0K
Apr 01, 2026 Sell	Common Stock F-InKind	Novack Jeffrey Adam Secretary And General Counsel	Officer	3 987 Value: $71.2K
Mar 31, 2026 Buy	Stock Option M-Exempt	Goldberg Michael Director	Director	11 500 Value: $14.0K
Mar 31, 2026 Buy	Stock Option (right to buy) M-Exempt	Goldberg Michael Director	Director	9 745 Value: $48.2K
Mar 31, 2026 Buy	Stock Option (right to buy) M-Exempt	Goldberg Michael Director	Director	5 255 Value: $26.4K
Mar 31, 2026 Buy	Common Stock M-Exempt	Goldberg Michael Director	Director	5 255 Value: $26.4K
Mar 31, 2026 Buy	Common Stock M-Exempt	Goldberg Michael Director	Director	9 745 Value: $48.2K
Mar 31, 2026 Buy	Common Stock M-Exempt	Goldberg Michael Director	Director	11 500 Value: $14.0K
Feb 03, 2026 Sell	Common Stock S-Sale	Novack Jeffrey Adam Secretary And General Counsel	Officer	4 441 Value: $91.3K
Feb 02, 2026 Buy	Common Stock A-Award	Hanna John Walter Jr President And CEO	CEO / President	162 500 Value: $3.32M
Feb 02, 2026 Sell	Common Stock F-InKind	Novack Jeffrey Adam Secretary And General Counsel	Officer	2 970 Value: $60.6K
Feb 02, 2026 Buy	Common Stock A-Award	Novack Jeffrey Adam Secretary And General Counsel	Officer	33 000 Value: $673.9K
Feb 02, 2026 Sell	Common Stock F-InKind	Novack Jeffrey Adam Secretary And General Counsel	Officer	2 492 Value: $50.9K
Feb 02, 2026 Buy	Common Stock A-Award	Smith Nathan Chief Financial Officer	C-Suite Officer	33 000 Value: $673.9K
Feb 02, 2026 Buy	Common Stock A-Award	Smith Nathan Chief Financial Officer	C-Suite Officer	7 875 Value: $160.8K
Feb 02, 2026 Buy	Common Stock A-Award	Meng Jessica Chief Commercial Officer	Officer	11 579 Value: $236.4K
Feb 02, 2026 Buy	Common Stock A-Award	Kennedy Keith Chief Operating Officer	C-Suite Officer	60 000 Value: $1.23M
Feb 02, 2026 Buy	Common Stock A-Award	Kennedy Keith Chief Operating Officer	C-Suite Officer	14 474 Value: $295.6K
Feb 02, 2026 Sell	Common Stock F-InKind	Kennedy Keith Chief Operating Officer	C-Suite Officer	4 644 Value: $94.8K
Feb 02, 2026 Sell	Common Stock F-InKind	Meng Jessica Chief Commercial Officer	Officer	4 430 Value: $90.5K
Feb 02, 2026 Buy	Common Stock A-Award	Meng Jessica Chief Commercial Officer	Officer	60 000 Value: $1.23M
Feb 02, 2026 Sell	Common Stock F-InKind	Smith Nathan Chief Financial Officer	C-Suite Officer	3 859 Value: $78.8K
Feb 02, 2026 Buy	Common Stock A-Award	Novack Jeffrey Adam Secretary And General Counsel	Officer	4 342 Value: $88.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CAREDX

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The co...

Read Full Profile Here